Search

Your search keyword '"ALAIMO G"' showing total 292 results

Search Constraints

Start Over You searched for: Author "ALAIMO G" Remove constraint Author: "ALAIMO G"
292 results on '"ALAIMO G"'

Search Results

4. T.07.7: CHARACTERISTICS AND MANAGEMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN SICILY: FIRST RESULTS OF THE HCC SICILY MULTIDISCIPLINARY NETWORK

7. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

10. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study

11. Gamma Glutamyl Transferase as a marker of risk of progression to cirrhosis in patients with Primary Biliary Cholangitis

12. Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network

13. A review of optical and thermal eye tissue parameters for improved computational models in retinal laser therapy

20. Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort

21. PC.01.10 LIVER AND CARDIOVASCULAR MORTALITY AFTER DAAS: DATA FROM THE RESIST-HCV COHORT

22. OC.07.1 DIRECT ACTING ANTIVIRALS AFTER SUCCESSFUL TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA IMPROVE SURVIVAL AND REDUCE HEPATIC DECOMPENSATION IN HCV-CIRRHOTIC PATIENTS

23. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

26. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

27. Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort

30. Prove e risultati

38. Non-invasive tools to ruling out large varices: RESIST-HCV vs Baveno VI criteria in a large cohort of patients with HCV cirrhosis

39. Intervento psicologico tramite la tecnica del diario in un gruppo di pazienti oncologici sottoposti a trattamento radioterapico

40. Ansia, Depressione e Qualità della Vita nei pazienti oncologici in trattamento radioterapico

41. Le attività sperimentali e il knowledge reuse

43. Integrated Strategy for Fast and Automated Molecular Characterization of Genes Involved in Craniosynostosis

45. Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort

47. The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing

49. PS-149 - Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort

50. Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort

Catalog

Books, media, physical & digital resources